NNPA NEWSWIRE — Molecular testing technologies help detect the presence of a virus by identifying a small section of the virus' genome, then amplifying that portion...
LONDON (MarketWatch) – GlaxoSmithKline PLC is selling its remaining rights to a drug for use in treating autoimmune diseases, including multiple sclerosis, to Novartis AG for...
$32 Billion in Funding Could Raise Awareness By Shantella Y. Sherman Special to the NNPA from the Afro-American Newspaper Lupus, or systemic lupus erythematosus, is a...
